Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Bioline RX, Mizrahi, Partner, Protalix: Israeli Equity Preview

Feb. 27 (Bloomberg) -- The following stocks may rise or fall in Israeli markets. Stock symbols are in parentheses after the company names and prices are from the close unless otherwise stated.

The TA-25 Index declined 1.8 percent to 1,272.62 in Tel Aviv.

Ampal-American Israel Corp. (AMPL IT): The flow of gas from Egypt may be delayed a few days, TheMarker business daily reported, citing an Israeli government evaluation. The holding company that imports the fuel earlier said it expected resumption by the end of February. Ampal-American dropped 2.9 percent to 7.066 shekels.

Bioline RX Ltd. (BLRX IT): The biopharmaceutical company said a trial to test the safety and effectiveness of BL-1040 in post heart-attack patients will start in the second half. Bioline declined 1.3 percent to 2.724 shekels.

Partner Communications Co. (PTNR IT): The country’s second-largest mobile phone company was raised to “market perform” from “underperform” at Meitav Investment House Ltd. Partner fell 1.7 percent to 66.87 shekels.

Protalix BioTherapeutics Inc. (PLX IT): The biotechnology company failed to win U.S. approval of a plant-based medicine it’s developing with Pfizer Inc. to treat Gaucher disease. Protalix gained 3.4 percent to 36.20 shekels.

Space Communication Ltd. (SCC IT): The supplier of satellite communications services said it plans to offer Series Yud-Aleph bonds under a shelf registration originally filed in February 2010. Space Communication slipped 0.2 percent to 69.86 shekels.

To contact the reporters on this story: Calev Ben-David in Jerusalem at cbendavid@bloomberg.net; Ronit Goodman in Tel Aviv at rgoodman9@bloomberg.net

To contact the editor responsible for this story: Claudia Maedler at cmaedler@bloomberg.net

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.